These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 33120166

  • 1. CTNNB1 p.L31P mutation in an ovarian endometrioid carcinoma with synchronous uterine endometrioid carcinoma.
    Pecorella I, Coppa A, Nicolussi A, Manganaro L, Fiorentin F, Palaia I, Muzii L.
    Pathol Res Pract; 2020 Dec; 216(12):153260. PubMed ID: 33120166
    [Abstract] [Full Text] [Related]

  • 2. Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis.
    Irving JA, Catasús L, Gallardo A, Bussaglia E, Romero M, Matias-Guiu X, Prat J.
    Hum Pathol; 2005 Jun; 36(6):605-19. PubMed ID: 16021566
    [Abstract] [Full Text] [Related]

  • 3. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
    Moreno-Bueno G, Gamallo C, Pérez-Gallego L, de Mora JC, Suárez A, Palacios J.
    Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles.
    McConechy MK, Ding J, Senz J, Yang W, Melnyk N, Tone AA, Prentice LM, Wiegand KC, McAlpine JN, Shah SP, Lee CH, Goodfellow PJ, Gilks CB, Huntsman DG.
    Mod Pathol; 2014 Jan; 27(1):128-34. PubMed ID: 23765252
    [Abstract] [Full Text] [Related]

  • 6. Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas.
    Catasús L, Bussaglia E, Rodrguez I, Gallardo A, Pons C, Irving JA, Prat J.
    Hum Pathol; 2004 Nov; 35(11):1360-8. PubMed ID: 15668893
    [Abstract] [Full Text] [Related]

  • 7. Synchronous ovarian endometrioid adenocarcinoma with a functioning stroma and endometrial endometrioid adenocarcinoma by different loss of heterozygosity findings.
    Takai N, Kai K, Tsuno A, Nasu K, Kashima K, Narahara H.
    Arch Gynecol Obstet; 2011 Oct; 284(4):951-5. PubMed ID: 21046134
    [Abstract] [Full Text] [Related]

  • 8. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
    Lin WM, Forgacs E, Warshal DP, Yeh IT, Martin JS, Ashfaq R, Muller CY.
    Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
    [Abstract] [Full Text] [Related]

  • 9. Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing - a case report.
    Valtcheva N, Lang FM, Noske A, Samartzis EP, Schmidt AM, Bellini E, Fink D, Moch H, Rechsteiner M, Dedes KJ, Wild PJ.
    BMC Cancer; 2017 Jan 19; 17(1):66. PubMed ID: 28103826
    [Abstract] [Full Text] [Related]

  • 10. Molecular evidence for a clonal relationship between synchronous uterine endometrioid carcinoma and ovarian clear cell carcinoma: a new example of "precursor escape"?
    Weng CH, Wu RC, Chen SJ, Chen HC, Tan KT, Lee YS, Huang SS, Yang LY, Wang CJ, Chou HH, Chao AS, Chao A, Lai CH.
    J Mol Med (Berl); 2021 Jul 19; 99(7):959-966. PubMed ID: 33768299
    [Abstract] [Full Text] [Related]

  • 11. Implication of genomic characterization in synchronous endometrial and ovarian cancers of endometrioid histology.
    Chao A, Wu RC, Jung SM, Lee YS, Chen SJ, Lu YL, Tsai CL, Lin CY, Tang YH, Chen MY, Huang HJ, Chou HH, Huang KG, Chang TC, Wang TH, Lai CH.
    Gynecol Oncol; 2016 Oct 19; 143(1):60-67. PubMed ID: 27498588
    [Abstract] [Full Text] [Related]

  • 12. Synchronous Endometrial and Ovarian Carcinomas: Pathologic and Molecular Analysis Highlights the Monoclonal Origin of the Lesions.
    Guerriero A, Moro M, Angerilli V, Munari G, Santoro L, Alessandrini L, Favero L, Tasca G, Fassan M, Dei Tos AP.
    Int J Gynecol Pathol; 2024 Jul 01; 43(4):309-315. PubMed ID: 37922918
    [Abstract] [Full Text] [Related]

  • 13. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N, Tsunoda H, Nishida M, Morishita Y, Takimoto Y, Kubo T, Noguchi M.
    Cancer Res; 2000 Dec 15; 60(24):7052-6. PubMed ID: 11156411
    [Abstract] [Full Text] [Related]

  • 14. Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas.
    Schultheis AM, Ng CK, De Filippo MR, Piscuoglio S, Macedo GS, Gatius S, Perez Mies B, Soslow RA, Lim RS, Viale A, Huberman KH, Palacios JC, Reis-Filho JS, Matias-Guiu X, Weigelt B.
    J Natl Cancer Inst; 2016 Jun 15; 108(6):djv427. PubMed ID: 26832770
    [Abstract] [Full Text] [Related]

  • 15. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
    Ma SK, Zhang HT, Sun YC, Wu LY.
    Zhonghua Zhong Liu Za Zhi; 2008 Sep 15; 30(9):690-4. PubMed ID: 19173912
    [Abstract] [Full Text] [Related]

  • 16. Molecular biological analysis revealed a case of synchronous endometrial and ovarian cancer with different histological grade as metastatic ovarian cancer from endometrial cancer: Case report and review of literature.
    Yumisashi R, Saito R, Togami S, Kobayashi Y, Kitazono I, Tanimoto A, Kobayashi H.
    J Obstet Gynaecol Res; 2023 Nov 15; 49(11):2766-2770. PubMed ID: 37604499
    [Abstract] [Full Text] [Related]

  • 17. Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression.
    Huang HN, Lin MC, Tseng LH, Chiang YC, Lin LI, Lin YF, Huang HY, Kuo KT.
    Histopathology; 2015 Mar 15; 66(4):517-28. PubMed ID: 25195947
    [Abstract] [Full Text] [Related]

  • 18. CTNNB1 Mutations and Aberrant β-Catenin Expression in Ovarian Endometrioid Carcinoma: Correlation With Patient Outcome.
    Zyla RE, Olkhov-Mitsel E, Amemiya Y, Bassiouny D, Seth A, Djordjevic B, Nofech-Mozes S, Parra-Herran C.
    Am J Surg Pathol; 2021 Jan 15; 45(1):68-76. PubMed ID: 32769429
    [Abstract] [Full Text] [Related]

  • 19. Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservation.
    Manning-Geist BL, Rios-Doria E, Liu YL, Ellenson LH, Zhou QC, Iasonos A, Leitao MM, Abu-Rustum NR, Weigelt B, Mueller JJ.
    Int J Gynecol Cancer; 2024 May 06; 34(5):697-704. PubMed ID: 38508587
    [Abstract] [Full Text] [Related]

  • 20. Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma.
    Guan B, Mao TL, Panuganti PK, Kuhn E, Kurman RJ, Maeda D, Chen E, Jeng YM, Wang TL, Shih IeM.
    Am J Surg Pathol; 2011 May 06; 35(5):625-32. PubMed ID: 21412130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.